| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2025 | Jul 24, 2025 | Lynx1 Capital Management LP 10% | Buy | Passage Bio, Inc. | PASG | $5.7 | $733,826 | +10.77% |
| May 19, 2025 | May 21, 2025 | Lynx1 Capital Management LP 10% | Buy | Tscan Therapeutics, Inc. | TCRX | $1.2 | $3M | +14.98% |
| Dec 27, 2024 | Dec 31, 2024 | Lynx1 Capital Management LP 10% | Buy | Passage Bio, Inc. | PASG | $0.65 | $241,038 | +3.88% |
| Dec 12, 2024 | Dec 16, 2024 | Lynx1 Capital Management LP 10% | Buy | Tscan Therapeutics, Inc. | TCRX | $2.93 | $385,769 | +1.23% |
| Nov 25, 2024 | Nov 27, 2024 | Lynx1 Capital Management LP 10% | Buy | Passage Bio, Inc. | PASG | $0.62 | $284,520 | +2.53% |
| Nov 15, 2024 | Nov 19, 2024 | Lynx1 Capital Management LP 10% | Buy | Tscan Therapeutics, Inc. | TCRX | $4.34 | $4,114 | +0.02% |
| May 31, 2023 | Jun 02, 2023 | Lynx1 Capital Management LP 10% | Sell | Tscan Therapeutics, Inc. | TCRX | $2.52 | $63,953 | -0.24% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.